Estrogen effects on the vascular wall.

Estrogen effects on the vascular wall. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Estrogen effects on the vascular wall. Abstract Text:

C van Breemen,

Estrogen effects on the vascular wall. Publishing Authors By Initials

C van Breemen,

For similar epidemiologic measurements: demography: sex distribution: sex ratio research abstracts see: epidemiologic measurements: demography: sex distribution: sex ratio research

PUBMED ID PMID:

MEDLINE DATE:

Estrogen effects on the vascular wall. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: The Canadian journal of cardiology

VOLUME: 14 Suppl D

Page Numbers: 18D-19D

Journal Abbreviation:

ISSN: 1916-7075

DAY: 3

MONTH: Jul

YEAR: 1998

Estrogen effects on the vascular wall. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8510280

Estrogen effects on the vascular wall. Keywords Mesh Terms:

KEYWORDS: Sex Ratio

MESH TERMS: pharmacology

Chemical & Substance for Abstract: Estrogen effects on the vascular wall. Information

Substance Name: Nitric Oxide

Registry Number: 10102-43-9

Grant and Affiliation Information for Estrogen effects on the vascular wall.

AFFILIATION: Department of Pharmacology and Therapeutics, University of British Columbia, Vancouver. breemen@unixg.ubc.ca

Country: CANADA

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Can J Cardiol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Estrogen effects on the vascular wall Related Publications

• Absorption and subcellular localization of lycopene in human prostate cancer cells.
• An improved LC-MS/MS method for the quantification of prostaglandins E(2) and D(2) production in biological fluids.
• Binding of the hop (Humulus lupulus L.) chalcone xanthohumol to cytosolic proteins in Caco-2 intestinal epithelial cells.
• Biotransformation of the chemopreventive agent 2',4',4-trihydroxychalcone (isoliquiritigenin) by UDP-glucuronosyltransferases.
• Ca2+ signaling in smooth muscle: TRPC6, NCX and LNats in nanodomains.
• Development of a Screening Assay for Ligands to the Estrogen Receptor Based on Magnetic Microparticles and LC-MS.
• Endothelial dysfunction and compromised eNOS/Akt signaling in the thoracic aorta during the progression of Marfan syndrome.
• Estrogen effects on the vascular wall.
• Imbalanced synthesis of cyclooxygenase-derived thromboxane A2 and prostacyclin compromises vasomotor function of the thoracic aorta in Marfan syndrome.
• In vitro metabolism of isoliquiritigenin by human liver microsomes.
• Increased matrix metalloproteinase 2 activity in the human internal mammary artery is associated with ageing, hypertension, diabetes and kidney dysfunction.
• Long-term doxycycline is more effective than atenolol to prevent thoracic aortic aneurysm in marfan syndrome through the inhibition of matrix metalloproteinase-2 and -9.
• Loss of elastic fiber integrity and reduction of vascular smooth muscle contraction resulting from the upregulated activities of matrix metalloproteinase-2 and -9 in the thoracic aortic aneurysm in Marfan syndrome.
• Quantitative analyses of beta-carotene and retinol in serum and feces in support of clinical bioavailability studies.
• Sites of alkylation of human Keap1 by natural chemoprevention agents.
• Transient receptor potential channel 6-mediated, localized cytosolic [Na+] transients drive Na+/Ca2+ exchanger-mediated Ca2+ entry in purinergically stimulated aorta smooth muscle cells.
• [In Process Citation]